当前位置:首页 - 行情中心 - 傲农生物(603363) - 财务分析 - 资产负债表

傲农生物

(603363)

  

流通市值:64.18亿  总市值:81.66亿
流通股本:21.47亿   总股本:27.31亿

资产负债表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
流动资产:
  货币资金475,419,354.55429,852,571.31697,570,126.52696,899,200.38
  交易性金融资产11,005,866.7511,002,734.841,112,832.61,208,843.64
  衍生金融资产-1,859,200-86,000
  应收票据及应收账款720,915,196.63718,861,969.37509,906,019.38706,781,222.06
  其中:应收票据--50,000-
        应收账款720,915,196.63718,861,969.37509,856,019.38706,781,222.06
  应收款项融资50,000300,000300,000200,000
  预付款项160,847,439.22147,570,782.23155,474,017.9137,051,566.63
  其他应收款合计881,058,709.01867,524,148.94840,059,622.77898,309,345.59
        应收股利2,587,982.852,587,982.852,587,982.852,587,982.85
  存货1,067,358,4841,161,837,223.06955,400,828.99887,771,099.63
  其他流动资产167,933,254.82172,193,200.73172,107,910.37193,773,704.81
  流动资产合计3,484,588,304.983,511,001,830.483,331,931,358.533,522,080,982.74
非流动资产:
  长期股权投资108,792,866.1108,497,368.59110,623,351.37121,555,769.57
  其他权益工具投资5,311,089.55,508,186.615,749,593.854,218,892.31
  其他非流动金融资产16,556,64016,556,64016,556,64037,356,640
  投资性房地产90,103,662.23114,017,492.49115,893,331.9149,188,153.06
  固定资产2,904,288,310.772,952,562,038.583,022,063,527.313,172,510,148.63
  在建工程445,263,899.67420,715,199.18421,801,478.26428,245,748.3
  生产性生物资产373,714,976.66354,208,374.83345,440,540.78318,671,660.46
  使用权资产357,828,190.55318,411,521.29324,468,937.22341,907,009.39
  无形资产311,349,941.88312,954,445.67315,958,304.24320,198,667.16
  商誉337,744,304.77337,744,304.77337,744,304.77357,209,598.98
  长期待摊费用161,393,180.78165,934,911.2167,818,000.63156,471,367.16
  递延所得税资产135,727,169.44136,837,863.9142,634,087.65179,466,806.16
  其他非流动资产80,421,064.9995,617,346.4883,253,280.83139,063,524.21
  非流动资产合计5,328,495,297.345,339,565,693.595,410,005,378.825,626,063,985.39
  资产总计8,813,083,602.328,850,567,524.078,741,936,737.359,148,144,968.13
流动负债:
  短期借款293,136,794.73319,697,500.27297,740,034.26366,228,929.98
  衍生金融负债789,54044,200673,68083,400
  应付票据及应付账款1,474,614,635.391,589,698,049.971,410,227,277.661,296,371,918.33
  其中:应付票据39,653,442.5124,524,211.3436,488,46821,922,259.4
        应付账款1,434,961,192.881,565,173,838.631,373,738,809.661,274,449,658.93
  合同负债134,558,964.87178,737,682.2138,275,293.96164,654,437.68
  应付职工薪酬72,428,131.7869,225,918.0187,986,782.674,345,493.48
  应交税费19,973,951.9819,258,123.7128,450,745.2924,382,975.2
  其他应付款合计1,240,376,433.871,002,564,858.881,022,628,644.931,045,866,482.88
  其中:应付利息33,133,031.0431,307,675.6329,281,018.9227,725,766.08
        应付股利1,532,00012,532,0001,532,0004,900,000
  一年内到期的非流动负债679,351,139.52598,034,998.09579,575,063.24474,293,639.19
  其他流动负债213,151.03322,861.49380,877.58567,178.81
  流动负债合计3,915,442,743.173,777,584,192.623,565,938,399.523,446,794,455.55
非流动负债:
  长期借款1,212,982,929.191,259,311,016.21,279,350,220.91,586,852,473.04
  租赁负债194,692,800.12163,060,829.83172,833,269.17187,150,545.64
  长期应付款10,352,825.55--539,406.43
  预计负债31,790,220.2531,790,220.2531,794,885.6927,574,748.6
  递延收益94,249,984.2197,400,814.6299,641,153.59101,599,013.48
  递延所得税负债11,593,544.1911,883,309.5412,175,596.1712,468,931.68
  非流动负债合计1,555,662,303.511,563,446,190.441,595,795,125.521,916,185,118.87
  负债合计5,471,105,046.685,341,030,383.065,161,733,525.045,362,979,574.42
所有者权益(或股东权益):
  实收资本(或股本)2,731,061,8262,602,961,8262,602,961,8262,602,961,826
  资本公积5,636,097,664.65,455,844,912.545,475,002,679.055,351,688,871.57
  减:库存股269,010,0000--
  其他综合收益-49,372,666.69-49,178,670.74-48,940,364.65-50,474,167.35
  盈余公积68,356,991.5668,356,991.5668,356,991.5668,356,991.56
  未分配利润-5,156,735,844.84-4,980,237,125.28-4,966,907,349.52-4,630,595,616.79
  归属于母公司股东权益合计2,960,397,970.633,097,747,934.083,130,473,782.443,341,937,904.99
  少数股东权益381,580,585.01411,789,206.93449,729,429.87443,227,488.72
  股东权益合计3,341,978,555.643,509,537,141.013,580,203,212.313,785,165,393.71
  负债和股东权益合计8,813,083,602.328,850,567,524.078,741,936,737.359,148,144,968.13
公告日期2026-08-312026-04-282026-04-232025-10-28
审计意见(境内)标准无保留意见
TOP↑